{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:35:53Z","timestamp":1787841353733,"version":"build-2784847793"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,6]],"date-time":"2015-01-06T00:00:00Z","timestamp":1420502400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,4]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is a rare autosomal recessive disorder. The mutation in the ECGF1 gene causes severe deficiency of thymidine phosphorylase (TP), which in turn increases thymidine and deoxyuridine in the blood, serum, and tissue. The toxic levels of these products cause malfunction of the mitochondrial respiratory chain and mitochondrial DNA. Commonly, patients become symptomatic between 15 and 20 years of age (range 5 months to 35 years). The most commonly affected systems are gastrointestinal, followed by ocular, and nervous system. The disease is often fatal; high mortality rate is reported between 20 and 40 years of age. Treatment modalities that can increase thymidine phosphorylase activity and decrease thymidine and deoxy-uridine have shown symptomatic improvements in patients with MNGIE. Platelet transfusion, hemodialysis, peritoneal dialysis or allogeneic hematopoietic stem cell transplantation (HSCT) have been tried. The survival and long-term benefits of these measures are still not clear. Engrafted patients after stem cell transplantation have showed improvements in serum thymidine and deoxyuridine. We are reporting a case of MNGIE from Saudi Arabia, who underwent allogeneic hematopoietic stem cell transplantation. No MNGIE case has been previously reported from Saudi Arabia or the Gulf Arab countries. From the available literature, so far only 11 patients with MNGIE have undergone stem cell transplantation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1016\/j.hemonc.2014.12.001","type":"journal-article","created":{"date-parts":[[2015,1,6]],"date-time":"2015-01-06T12:33:55Z","timestamp":1420547635000},"page":"85-90","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["Mitochondrial Neurogastrointestinal Encephalomyopathy Treated with Stem Cell Transplantation"],"prefix":"10.4103","volume":"8","author":[{"given":"Musthafa Chalikandy","family":"Peedikayil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eje Ingvar","family":"Kagevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehab","family":"Abufarhaneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moeenaldeen Dia","family":"Alsayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazzaa Abdulla","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"Pt. 11","key":"10.1016\/j.hemonc.2014.12.001_b0005","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1093\/brain\/awr245","article-title":"Clinical and genetic spectrum of mitochondrial neurogastrointestinal encephalomyopathy","volume":"134","author":"Garone","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.hemonc.2014.12.001_b0010","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.gene.2005.04.041","article-title":"Thymidine phosphorylase mutations cause instability of mitochondrial DNA","volume":"354","author":"Hirano","year":"2005","journal-title":"Gene"},{"issue":"6","key":"10.1016\/j.hemonc.2014.12.001_b0015","doi-asserted-by":"crossref","first-page":"4128","DOI":"10.1074\/jbc.M111028200","article-title":"Altered thymidine metabolism due to defects of thymidine phosphorylase","volume":"277","author":"Spinazzola","year":"2002","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.hemonc.2014.12.001_b0020","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1212\/01.wnl.0000239824.95411.52","article-title":"Infusion of platelets transiently reduces nucleoside overload in MNGIE","volume":"67","author":"Lara","year":"2006","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.hemonc.2014.12.001_b0025","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/jms.1013","article-title":"Pre- and post-dialysis quantitative dosage of thymidine in urine and plasma of a MNGIE patient by using HPLC-ESI-MS\/MS","volume":"41","author":"la Marca","year":"2006","journal-title":"J Mass Spectrom"},{"issue":"8","key":"10.1016\/j.hemonc.2014.12.001_b0030","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1212\/01.wnl.0000240853.97716.24","article-title":"Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE","volume":"67","author":"Hirano","year":"2006","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.hemonc.2014.12.001_b0035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0022-510X(76)90236-7","article-title":"Congenital oculoskeletal myopathy with abnormal muscle and liver mitochondria","volume":"27","author":"Okamura","year":"1976","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.hemonc.2014.12.001_b0040","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/01.nrl.0000106919.06469.04","article-title":"Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a disease of two genomes","volume":"10","author":"Hirano","year":"2004","journal-title":"Neurologist"},{"issue":"7","key":"10.1016\/j.hemonc.2014.12.001_b0045","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.ejhg.5201002","article-title":"Novel POLG mutations in progressive external ophthalmoplegia mimicking mitochondrial neurogastrointestinal encephalomyopathy","volume":"11","author":"Van Goethem","year":"2003","journal-title":"Eur J Hum Genet"},{"issue":"6","key":"10.1016\/j.hemonc.2014.12.001_b0050","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s10545-011-9332-6","article-title":"Pitfalls in diagnosing mitochondrial neurogastrointestinal encephalomyopathy","volume":"34","author":"Filosto","year":"2011","journal-title":"J Inherit Metab Dis"},{"issue":"5402","key":"10.1016\/j.hemonc.2014.12.001_b0055","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.283.5402.689","article-title":"Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder","volume":"283","author":"Nishino","year":"1999","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.hemonc.2014.12.001_b0060","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/archneur.64.3.435","article-title":"Treatment of mitochondrial neurogastrointestinal encephalomyopathy with dialysis","volume":"64","author":"Yavuz","year":"2007","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.hemonc.2014.12.001_b0065","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/bmt.2010.100","article-title":"Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach","volume":"46","author":"Halter","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.hemonc.2014.12.001_b0070","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1007\/s00415-012-6572-9","article-title":"Course and management of allogeneic stem cell transplantation in patients with mitochondrial neurogastrointestinal encephalomyopathy","volume":"259","author":"Filosto","year":"2012","journal-title":"J Neurol"}],"container-title":["Hematology\/Oncology and Stem Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1658387614001113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1658387614001113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ovid.com\/02275670-201508020-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:50:20Z","timestamp":1787838620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/02275670-201508020-00006"}},"subtitle":["A Case Report and Review of Literature"],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1016\/j.hemonc.2014.12.001","relation":{},"ISSN":["1658-3876"],"issn-type":[{"value":"1658-3876","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}